Wainwright

• Press releases
• Country: United States

NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright’s AI-Based Drug Discovery and Development Conference

TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc . (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Dr.…

• Country: Cyprus

H.C. Wainwright reiterates Sol Gel stock rating ahead of trial data

• Country: Cyprus

H.C. Wainwright reiterates Korro Bio stock rating on trial dosing

• Press releases
• Country: United States

Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference

HOLON, ISRAEL, Oct. 6, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI, today announced that management will participate in a fireside chat at the H.C. Wainwright 3rd...

• Country: Cyprus

H.C. Wainwright reiterates Orchestra BioMed stock rating on trial enrollment

• Country: Cyprus

H.C. Wainwright reiterates Cognition Therapeutics stock rating ahead of FDA meeting

• Country: Cyprus

H.C. Wainwright reiterates Buy on CervoMed stock on new formulation